Retail & Consumer Intelligence
Health & Wellness Retail
Real-time intelligence, expert analysis, and verified research for the Health & Wellness Retail industry. Stay ahead in 3 minutes a day.
Stay ahead of Health & Wellness Retail in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
Target Removes Cereals with Artificial Dyes Citing Child Health Concerns
Target plans to remove cereals containing synthetic food dyes by month's end following FDA regulations and studies linking dyes to behavioral issues.
Read full articleOral Weight-Loss Pills Draw Patients from Compounded GLP-1 Drugs
Lower-cost oral obesity drugs from Novo Nordisk and Eli Lilly are attracting patients away from compounded GLP-1 therapies, reshaping market dynamics.
Read full articleEli Lilly's Retatrutide Shows 70-Pound Weight Loss in Clinical Trial
Experimental triple-agonist drug retatrutide achieved average 70.3-pound weight loss over 80 weeks, comparable to bariatric surgery results.
Read full articleRFK Jr. Fires Top Preventive Services Task Force Leaders
HHS Secretary Kennedy removed USPSTF vice chairs, raising concerns about politicization of evidence-based preventive care recommendations.
Read full articleHealth Systems Seek Role in AI Cybersecurity Initiative
Hospital CIOs push to join Anthropic's Project Glasswing as AI model Claude Mythos raises cybersecurity concerns for healthcare infrastructure.
Read full articleTarget Removes Cereals with Artificial Dyes Citing Child Health Concerns
Target plans to remove cereals containing synthetic food dyes by month's end following FDA regulations and studies linking dyes to behavioral issues.
Read full articleOral Weight-Loss Pills Draw Patients from Compounded GLP-1 Drugs
Lower-cost oral obesity drugs from Novo Nordisk and Eli Lilly are attracting patients away from compounded GLP-1 therapies, reshaping market dynamics.
Read full articleEli Lilly's Retatrutide Shows 70-Pound Weight Loss in Clinical Trial
Experimental triple-agonist drug retatrutide achieved average 70.3-pound weight loss over 80 weeks, comparable to bariatric surgery results.
Read full articleRFK Jr. Fires Top Preventive Services Task Force Leaders
HHS Secretary Kennedy removed USPSTF vice chairs, raising concerns about politicization of evidence-based preventive care recommendations.
Read full articleHealth Systems Seek Role in AI Cybersecurity Initiative
Hospital CIOs push to join Anthropic's Project Glasswing as AI model Claude Mythos raises cybersecurity concerns for healthcare infrastructure.
Read full articleStay ahead of Health & Wellness Retail in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.